Clinical Trial: GOG Foundation GOG-3024/GCT1015-05

GOG Foundation GOG-3024/GCT1015-05

Status: Closed

NCT#03786081

A Phase 1b/2 Open-Label Trial of Tisotumab Vedotin (HuMax-TF-ADC) in Combination with Other Agents in Subjects with Recurrent or Stage IVB Cervical Cancer

Limited institution study - Billings Clinic Only

Enrollment completed December 15, 2020.

The Montana Cancer Consortium (MCC) is an independent nonprofit organization whose mission is to bring state-of-the-art cancer care to Montana, Idaho and Wyoming through National Cancer Institute (NCI) sponsored clinical research.

Available Clinical Trials

Clinical Trial: GOG Foundation GOG-3024/GCT1015-05

GOG Foundation GOG-3024/GCT1015-05

NCT#03786081

Navigation

About Us

Contact Us